TMS and Exercise for Post-stroke Pain

NCT ID: NCT04672044

Last Updated: 2025-06-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-14

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are over 7 million people living with stroke in the United States. Per year, approximately 17,000 Veterans are admitted to the VA for acute stroke. Chronic pain after stroke can occur between 10-50% of stroke survivors. Post-stroke pain (PSP) can lead to further complications in a stroke survivor's recovery. Exercise has improved PSP and associated symptoms such as mobility, fatigue, and quality of life. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique using electromagnetic induction for cortical neurostimulation. The use of rTMS has been explored shown to be effective in treating chronic PSP but is limited in effect duration. Our proposal will test the hypothesis that rTMS is feasible and safe to be paired with exercise. Additionally, the investigators believe a complementary effect can develop to enhance the neurostimulation duration of rTMS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Post-stroke Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Feasibility of a double-blind sham-controlled intervention
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Double-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

active rTMS+Exercise

active rTMS

Group Type ACTIVE_COMPARATOR

Active rTMS and exercise

Intervention Type DEVICE

active

sham rTMS+Exercise

sham rTMS

Group Type SHAM_COMPARATOR

Sham rTMS+Exercise

Intervention Type COMBINATION_PRODUCT

sham

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active rTMS and exercise

active

Intervention Type DEVICE

Sham rTMS+Exercise

sham

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female Veteran of US military 19 years of age
* Signed informed consent
* Minimum of 3-months since time of stroke and medically stable
* Headache has persisted for \>3 months after stabilization of the stroke
* Ability to walk or tolerate recumbent cycle ergometry for 10 mins without assistance
* Stable pain medication regimen for 1 month prior to study
* Females of child-bearing potential (i.e. not postmenopausal or surgically sterile) must be using a medically acceptable method of birth control and should not be pregnant nor have plans for pregnancy or breastfeeding during the study
* Completed diagnostic, maximal graded exercise test including 12-lead ECG and indirect calorimetry (i.e. oxygen uptake, minute ventilation, respiratory exchange ratio, etc.)
* Minimum pain intensity of 30 on the Mechanical Visual Analogue Scale on average with pain symptoms.

Exclusion Criteria

* Moderate to severe cognitive impairment (Montreal Cognitive Assessment score \<16/30)
* Pre-stroke modified Rankin \>2
* History of seizures
* Presence of any standard TMS or MRI contraindications (see human subjects)
* Current diagnosis of DSM-5-defined bipolar disorder I, schizophrenia, schizoaffective disorder, or obsessive-compulsive disorder
* Diagnosis of moderate or severe substance use disorder (except for caffeine and nicotine) during the preceding 3 months (Participants must agree to abstain from illicit drugs during the study)
* Increased risk of suicide that necessitates inpatient treatment or warrants additional therapy excluded by the protocol; and/or intensity of suicidal ideation (Type 4 or Type 5) or any suicidal behavior in the past 3 months on Columbia Suicide Severity Rating Scale (C-SSRS)
* Litigating for compensation for a psychiatric disorder

* Veterans who are in the process of applying for or receiving VA service-connected disability are eligible
* Current enrollment in another intervention trial for pain or stroke
* Persons imprisoned, of minor age, diagnosed with terminal illness, or require surrogate for consent
* Fails baseline exercise screening activities
* Persistent post-stroke headaches not better accounted for by another diagnosis
* Is unable to reliably attend intervention sessions i.e. planning to move, transportation issues
* Neurological disorder pre- or post- stroke affecting subject's ability to follow study directions
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chen Lin, MD

Role: PRINCIPAL_INVESTIGATOR

Birmingham VA Medical Center, Birmingham, AL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham VA Medical Center, Birmingham, AL

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Lin C, Morgan CJ, Fortenberry ELS, Androulakis XM, McGregor K. The safety and feasibility of a pilot randomized clinical trial using combined exercise and neurostimulation for post-stroke pain: the EXERT-Stroke study. Front Neurol. 2025 Apr 24;16:1524004. doi: 10.3389/fneur.2025.1524004. eCollection 2025.

Reference Type DERIVED
PMID: 40343185 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I21RX003612

Identifier Type: NIH

Identifier Source: secondary_id

View Link

B3612-P

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TMS in Aphasia Recovery
NCT04777214 COMPLETED NA
Post-Stroke Aphasia TMS
NCT06974279 RECRUITING NA
Accelerated rTMS vs. Sham for Stroke Apathy
NCT07113067 RECRUITING PHASE1/PHASE2